Decreased Behavioral Abnormalities After Treatment with Combined Donepezil and Yokukansankachimpihange in Alzheimer Disease: An Observational Study. The Osaki-Tajiri Project

11Citations
Citations of this article
50Readers
Mendeley users who have this article in their library.

Abstract

Introduction: Yokukansan is one of the traditional herbal medicines (Kampo medicine in Japan) commonly used in the treatment of the Behavioral and Psychological Symptoms of Dementia (BPSD). We performed an observational study using yokukansankachimpihange, which contains a nobiletin-rich Citrus reticulata, to determine whether it could improve BPSD as well as cognitive impairment in patients with Alzheimer disease (NINCDS-ADRDA). Methods: Forty-six (23 vs. 23) patients were enrolled in the study sample (donepezil group vs. donepezil + yokukansankachimpihange group). The BPSD were assessed using the Frequency-Weighted Behavioral Pathology in Alzheimer Disease Rating Scale (BEHAVE-AD-FW). The Mini-Mental State Examination and the Digit Symbol test of WAIS-R were used to evaluate impairment of global cognitive function and executive function, respectively. Results: No significant changes in the cognitive functions or the total BPSD scores were noted for either treatment group. Regarding the subscales of the BPSD, the subscale of Diurnal Rhythm showed a significant decrease after the treatment, and those of Affective Disturbance and Anxiety and Phobias tended to be decreased. The donepezil + yokukansankachimpihange group had a lower rate of use of anti-psychotics compared with the donepezil group, although this was not statistically significant. Conclusion: These results suggest that combined treatment of yokukansankachimpihange with donepezil has a positive clinical effect on improving the behavioral abnormalities, despite the lack of any effect on cognitive functions. Improvements in the diurnal rhythm may improve affective disturbance and anxiety. Thus, yokukansankachimpihange is considered to have a mild stabilizing effect on emotion.

References Powered by Scopus

"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician

77789Citations
N/AReaders
Get full text

Clinical diagnosis of alzheimer’s disease: Report of the NINCDS-ADRDA work group⋆ under the auspices of department of health and human services task force on alzheimer’s disease

26484Citations
N/AReaders
Get full text

Cholinesterase inhibitors for Alzheimer's disease

1733Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Nobiletin Ameliorates NLRP3 Inflammasome-Mediated Inflammation Through Promoting Autophagy via the AMPK Pathway

54Citations
N/AReaders
Get full text

Non-Enzymatic Antioxidants against Alzheimer’s Disease: Prevention, Diagnosis and Therapy

20Citations
N/AReaders
Get full text

An update on citrus polymethoxyflavones: chemistry, metabolic fate, and relevant bioactivities

9Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Meguro, K., & Yamaguchi, S. (2018). Decreased Behavioral Abnormalities After Treatment with Combined Donepezil and Yokukansankachimpihange in Alzheimer Disease: An Observational Study. The Osaki-Tajiri Project. Neurology and Therapy, 7(2), 333–340. https://doi.org/10.1007/s40120-018-0109-9

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 19

83%

Lecturer / Post doc 2

9%

Professor / Associate Prof. 1

4%

Researcher 1

4%

Readers' Discipline

Tooltip

Psychology 8

40%

Pharmacology, Toxicology and Pharmaceut... 6

30%

Nursing and Health Professions 3

15%

Medicine and Dentistry 3

15%

Article Metrics

Tooltip
Mentions
News Mentions: 1
Social Media
Shares, Likes & Comments: 6

Save time finding and organizing research with Mendeley

Sign up for free